Smartphone applications for remote patient monitoring reduces clinic utilization after full-endoscopic spine surgery.
Telecare
full-endoscopic spine-surgery
remote patient monitoring
smartphone application
spinal surgery
telemedicine
Journal
Journal of telemedicine and telecare
ISSN: 1758-1109
Titre abrégé: J Telemed Telecare
Pays: England
ID NLM: 9506702
Informations de publication
Date de publication:
06 Feb 2024
06 Feb 2024
Historique:
medline:
7
2
2024
pubmed:
7
2
2024
entrez:
7
2
2024
Statut:
aheadofprint
Résumé
The rising number of outpatient spine surgeries creates challenges in postoperative management and care. Telemedicine offers a unique opportunity to reduce in-person clinic visits and improve resource allocation. We aimed to investigate the impact of a validated smartphone application on clinic utilization following full-endoscopic spine surgery (FESS). We evaluated patients undergoing FESS from 2020 to 2022 and a pre-COVID control group (CG) from 2018 to 2019. Subsequently, we divided the patients into three groups: one using the application (intervention group, IG), and two CGs (2020-2022, CG and 2018-2019, historical control group (HG)). We analyzed the post-surgical hospitalization rate, all follow-ups, and virtually transmitted patient-reported outcomes. A total of 115 patients were included in the IG. The CG consisted of 137 and the HG of 202 patients (CG and HG in the following). Group homogeneity was satisfactory regarding patient age ( Our results underline the feasibility, efficacy, and safety of remote patient monitoring following FESS. Furthermore, they highlight the opportunity to implement a virtual wound checkup, and to substantially improve postoperative follow-up compliance via telemedicine.
Identifiants
pubmed: 38321874
doi: 10.1177/1357633X241229466
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1357633X241229466Déclaration de conflit d'intérêts
Declaration of conflicting interestsDr. Hofstetter is a consultant for Joimax, Globus Medical, Innovasis, and Johnson & Johnson. The application is owned by the University of Washington and is used as a research and quality improvement tool without any commercial use. The other authors declare no conflicts of interest.